GRK2 Orchestrates VSMC Phenotypic Modulation via DNMT1-Mediated DNA Methylation Reprogramming
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025
DOI: 10.1161/atvbaha.125.322645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Chao-Hua Kong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, China (C.-h.K., Y.S., L.-d.W., W.-y.Z., D.-c.W., Z.-h.J., X.-m.J., P.Y.…. Hauptthemen laut MEDLINE: DNA (Cytosine-5-)-Methyltransferase 1, Muscle, Smooth, Vascular, DNA Methylation, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Vascular smooth muscle cell (VSMC) phenotypic modulation is responsible for the pathogenesis of hyper-muscularized arterial diseases. Recent studies have highlighted the critical role of epigenetic regulation in VSMC fate. However, the mechanisms underlying the precise regulation of the epigenetic machinery in VSMC remain unclear. METHODS: Using mouse aortic smooth muscle cells, carotid artery injury mouse model, and human atherosclerosis data sets, we identified GRK2 (G-protein–coupled receptor kinase 2) as a novel epigenetic regulator governing VSMC fate. RESULTS: GRK2 expression was found to be elevated in dedifferentiated VSMCs. Pharmacological or genetic silencing of GRK2 inhibited VSMC phenotypic switching. Mechanistic investigations demonstrated that GRK2 modulated VSMC phenotype via DNMT1 (DNA methyltransferase 1)-mediated DNA methylation. GRK2 phosphorylated DNMT1, stabilizing it by modulating its ubiquitination. Hypermethylated VSMC exhibited reduced expression of contractile-associated proteins. Inhibition of DNMT1 abolished the effects of GRK2 overexpression on VSMC phenotype, indicating a DNMT1-mediated mechanism. CONCLUSIONS: Our findings revealed that the GRK2-DNMT1 signaling axis is a critical regulator in VSMC phenotypic switching and present a potential therapeutic target for vascular remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, China (C.-h.K., Y.S., L.-d.W., W.-y.Z., D.-c.W., Z.-h.J., X.-m.J., P.Y., Y.G., A.-q.C., Y.-l.C., S.-l.C.).
- Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, The 14th Five-Year Plan Application Charactseristic Discipline of Hunan Province (Pharmaceutical Science), College of…
ORCID-Profile: Yue Sun, Li-da Wu, Wen-Ying Zhou, Dong-Chen Wang, Yue Gu, Ai-Qun Chen, Jin-Que Luo, Yue-Lin Chao, Shao-Liang Chen
Zitieren
APA
Kong, C. H., Sun, Y., Wu, L. D., Zhou, W. Y., Wang, D. C., Jiang, Z. H., Jiang, X. M., Ye, P., Gu, Y., Chen, A. Q., Luo, J. Q., Chao, Y. L., & Chen, S. L. (2025). GRK2 Orchestrates VSMC Phenotypic Modulation via DNMT1-Mediated DNA Methylation Reprogramming. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.322645
Vancouver
Kong CH, Sun Y, Wu LD, Zhou WY, Wang DC, Jiang ZH, et al. GRK2 Orchestrates VSMC Phenotypic Modulation via DNMT1-Mediated DNA Methylation Reprogramming. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.125.322645
BibTeX
@article{Kong2025,
author = {Kong, Chao-Hua and Sun, Yue and Wu, Li-da and Zhou, Wen-Ying and Wang, Dong-Chen and Jiang, Zi-Hao and Jiang, Xiao-Min and Ye, Peng and Gu, Yue and Chen, Ai-Qun and Luo, Jin-Que and Chao, Yue-Lin and Chen, Shao-Liang},
title = {GRK2 Orchestrates VSMC Phenotypic Modulation via DNMT1-Mediated DNA Methylation Reprogramming},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
doi = {10.1161/atvbaha.125.322645}
}
EUVIMED